Evaluation of Valvular Heart Disease Using Cardiac CT
ConditionValvular Heart Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorToho University
About this trial
The EVIDENTIA Registry is a multicenter study designed to evaluate valvular heart disease (VHD) using cardiac CT. It aims to assess cardiac valve anatomy, function, and myocardial characteristics through detailed CT analysis.
1. Assessing the accuracy of cardiac CT in evaluating cardiac structure, volume, function, and myocardium in VHD patients. 2. Comparing the severity, classification, and etiology (primary vs. functional) of VHD. 3. Monitoring serial changes in VHD severity via echocardiography. 4. Investigating the relationship between echocardiographic and CT-derived parameters. 5. Examining the correlation between imaging findings, VHD interventions, and patient prognosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with at least moderate valvular heart disease who had a cardiac CT with 64 or more rows
18 years of age or older
Disqualifiers
Less than 18 years old
Acute VHD
Infectious endocarditis
Patients with post-VHD intervention
Trial population
The study will be conducted at 7 centers throughout Japan, with the goal of enrolling a total of approximately 300-350 cases.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
the 1-year composite endpoint of all-cause death and major cardiac adverse events (MACE) including VHD intervention.
Time frame
one yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov